Angiogenesis related Compound Library

Description: - A unique collection of 2300 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);- Targets include angiogenesis signaling, and related targets such as S1P, VEGFR, PDGF, etc.;- Includes approved drugs targeting angiogenesis, such as Sunitinib Malate, Lenalidomide, sorafenib, Erlotinib; drugs in clinical development with the most potential targeting angiogenesis, such as Vatalanib, Orantinib, 2-Methoxyestradiol (Panzem), Celecoxib;- Detailed compound information with structure, target, activity, IC50 value, and biological activity description;- Structurally diverse, medicinally active, and cell permeable;- NMR and HPLC validated to ensure high purity and quality;

• Artikelnummer: TGML4800-30uL
• Hersteller: TargetMol Chemicals
• Hersteller Artikelnummer: L4800-30uL
• Verpackungseinheit: 30 μL
• Mengeneinheit: STK